Literature DB >> 23389591

First 'breakthrough' drugs designated, but dilution worries linger.

Elie Dolgin.   

Abstract

Mesh：

Year:  2013        PMID： 23389591     DOI： 10.1038/nm0213-116

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

Review 1.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

2.  Cancer's true breakthroughs.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2013-06-02       Impact factor: 53.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.